Stock 002433 GUANGDONG TAIANTANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Guangdong Taiantang Pharmaceutical Co., Ltd.

Equities

002433

CNE100000Q92

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 01/07/2024 BST 		5-day change 1st Jan Change
0.29 CNY -3.33% Intraday chart for Guangdong Taiantang Pharmaceutical Co., Ltd. +7.41% -87.76%
06-13 Guangdong Taiantang Pharmaceutical Co., Ltd.(SZSE:002433) dropped from Shenzhen Stock Exchange Composite Index CI
06-13 Guangdong Taiantang Pharmaceutical Co., Ltd.(SZSE:002433) dropped from Shenzhen Stock Exchange A Share Index CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shantou Real Estate Hexin Co., Ltd. acquired Shantou Tai'an Investment Development Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for CNY 240 million.
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Shantou Real Estate Hexin Co., Ltd. agreed to acquire Shantou Tai'an Investment Development Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for CNY 240 million.
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Chengdu Yiyun Technology Co., Ltd. completed the acquisition of a 47.35% stake in Guangdong Kangaiduo Digital Health Technology Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd..
CI
Guangdong Hongding Real Estate Investment Development Group Co., Ltd. agreed to acquire 25% stake in Guangzhou Jinpibao Property Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for approximately CNY 220 million.
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Not to Pay Dividend for the Year 2020
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Chengdu Yiyun Technology Co., Ltd. agreed to acquire a 47.35% stake in Guangdong Kangaiduo Digital Health Technology Co., Ltd. from Guangdong Taiantang Pharmaceutical Co., Ltd. for approximately CNY 750 million.
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Guangdong Taiantang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002433 Stock
  4. News Guangdong Taiantang Pharmaceutical Co., Ltd.
  5. Highlights